Sparton Corporation  

(Public, NYSE:SPA)   Watch this stock  
Find more results for SPA
24.08
+0.60 (2.56%)
After Hours: 24.08 0.00 (0.00%)
Oct 23, 4:23PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 23.49 - 24.29
52 week 22.00 - 33.81
Open 23.73
Vol / Avg. 24,434.00/48,104.00
Mkt cap 239.42M
P/E 18.82
Div/yield     -
EPS 1.28
Shares 10.13M
Beta 1.73
Inst. own 67%
Aug 26, 2014
Sparton Corp at Three Part Advisors Midwest IDEAS Investor Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 3.18% 3.86%
Operating margin 5.28% 5.92%
EBITD margin - 8.45%
Return on average assets 6.08% 7.12%
Return on average equity 11.00% 12.60%
Employees 1,385 -
CDP Score - -

Address

Suite 2050, 425 N. Martingale Road
SCHAUMBURG, IL 60173
United States - Map
+1-847-7625800 (Phone)
+1-517-7871822 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sparton Corporation and subsidiaries (Sparton) is a provider of electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, and field service. The Company serves the Medical, Military and Aerospace and Industrial and Instrumentation markets through three reportable business segments: Medical Device (Medical), Complex Systems (CS) and Defense & Security Systems (DSS). The Company's products and services include products for original equipment manufacturers (OEM) and emerging technology (ET) customers that are microprocessor-based systems that include transducers, printed circuit boards and assemblies, sensors, and electromechanical components, as well as development and design engineering services relating to these product sales. In March 2014, the Company acquired Aubrey Group, Inc.

Officers and directors

James R. Swartwout Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Cary B. Wood President, Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Donald W. Pearson Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
Michael W. Osborne Senior Vice President - Corporate Development
Age: 43
Bio & Compensation  - Reuters
Steven M. Korwin Senior Vice President - Quality, Engineering and Information Systems
Age: 51
Bio & Compensation  - Reuters
Gordon B. Madlock Senior Vice President - Operations
Age: 56
Bio & Compensation  - Reuters
Lawrence R. Brand Vice President - Human Resources
Age: 47
Bio & Compensation  - Reuters
Mike Gaul Group Vice President - Medical Manufacturing
Age: 60
Bio & Compensation  - Reuters
James M. Lackemacher Group Vice President - DSS Engineered Products
Age: 52
Bio & Compensation  - Reuters
Christopher Ratliff Vice President - Information Technology
Age: 49
Bio & Compensation  - Reuters